Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
2021
Gerrits, Emma | Brouwer, Nieske | Kooistra, Susanne M. | Woodbury, Maya E. | Vermeiren, Yannick | Lambourne, Mirjam | Mulder, Jan | Kummer, Markus | Möller, Thomas | Biber, Knut | den Dunnen, Wilfred F.A. | De Deyn, Peter P. | Eggen, Bart J.L. | Boddeke, Erik W.G.M.
Alzheimer’s disease (AD) is the most prevalent form of dementia and is characterized by abnormal extracellular aggregates of amyloid-β and intraneuronal hyperphosphorylated tau tangles and neuropil threads. Microglia, the tissue-resident macrophages of the central nervous system (CNS), are important for CNS homeostasis and implicated in AD pathology. In amyloid mouse models, a phagocytic/activated microglia phenotype has been identified. How increasing levels of amyloid-β and tau pathology affect human microglia transcriptional profiles is unknown. Here, we performed snRNAseq on 482,472 nuclei from non-demented control brains and AD brains containing only amyloid-β plaques or both amyloid-β plaques and tau pathology. Within the microglia population, distinct expression profiles were identified of which two were AD pathology-associated. The phagocytic/activated AD1-microglia population abundance strongly correlated with tissue amyloid-β load and localized to amyloid-β plaques. The AD2-microglia abundance strongly correlated with tissue phospho-tau load and these microglia were more abundant in samples with overt tau pathology. This full characterization of human disease-associated microglia phenotypes provides new insights in the pathophysiological role of microglia in AD and offers new targets for microglia-state-specific therapeutic strategies.
显示更多 [+] 显示较少 [-]